Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100XTMG
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥29m2025-01-01 → 2025-12-31StandaloneNet sales
Revenue¥31m2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥63m2023-01-01 → 2023-12-31vStandaloneNet sales (5-year summary)
Revenue¥976m2022-01-01 → 2022-12-31vStandaloneNet sales (5-year summary)
Revenue¥642m2021-01-01 → 2021-12-31vStandaloneNet sales (5-year summary)
Operating income−¥2.0bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income−¥2.1bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥1.9bn2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥2.1bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax−¥1.7bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income−¥2.1bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income−¥1.7bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥1.9bn2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income−¥1.1bn2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income−¥1.6bn2021-01-01 → 2021-12-31vStandaloneNet income loss (5-year summary)
Total assets¥4.6bnat 2025-12-31StandaloneAssets
Total assets¥3.2bnat 2024-12-31StandaloneAssets
Total assets¥2.0bnat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥2.7bnat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥4.3bnat 2021-12-31vStandaloneTotal assets (5-year summary)
Total liabilities¥556mat 2025-12-31StandaloneLiabilities
Total liabilities¥447mat 2024-12-31StandaloneLiabilities
Net assets / equity¥4.0bnat 2025-12-31StandaloneNet assets
Net assets / equity¥2.8bnat 2024-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2023-12-31vStandaloneNet assets
Net assets / equity¥2.2bnat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥3.6bnat 2021-12-31vStandaloneNet assets (5-year summary)
Cash and deposits¥3.7bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥2.4bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥3.4bnat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31vStandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.2bnat 2021-12-31vStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.9bn2025-01-01 → 2025-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥2.0bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥20m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥942,0002021-01-01 → 2021-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.2bn2025-01-01 → 2025-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.9bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥114m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-802025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-77.172024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-108.922023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31vStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥136.38at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥110.4at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥74.35at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥124.2at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥206.86at 2021-12-31vStandaloneNet assets per share (5-year summary)
Equity ratio87.6%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.5%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio81.2%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31vStandaloneEquity to asset ratio (5-year summary)
Shares issued29,291,600at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,961,600at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,717,100at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31vStandaloneTotal number of issued shares (5-year summary)
Employees38at 2025-12-31StandaloneNumber of employees
Employees35at 2024-12-31StandaloneNumber of employees
Employees34at 2023-12-31vStandaloneNumber of employees
Employees33at 2022-12-31vStandaloneNumber of employees
Employees33at 2021-12-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 834
ItemContextValueUnit
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember3242920000JPY
Capital reductionCurrentYearDuration_NonConsolidatedMember－JPY
Deficit dispositionCurrentYearDuration_NonConsolidatedMember－JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember-1000JPY
Disposal of treasury stockCurrentYearDuration_NonConsolidatedMember126000JPY
Gain on disposal of treasury stockCurrentYearDuration_NonConsolidatedMember62763000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-2058049000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember－JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember1247760000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember7680000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember3999969000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember-1681015000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember-2054016000JPY
Depreciation and amortization ope cfPrior1YearDuration_NonConsolidatedMember815000JPY
Depreciation and amortization ope cfCurrentYearDuration_NonConsolidatedMember242000JPY
Impairment loss ope cfPrior1YearDuration_NonConsolidatedMember17104000JPY
Impairment loss ope cfCurrentYearDuration_NonConsolidatedMember2772000JPY
Amortization of restricted stock remuneration ope cfPrior1YearDuration_NonConsolidatedMember6205000JPY
Amortization of restricted stock remuneration ope cfCurrentYearDuration_NonConsolidatedMember6098000JPY
Share based compensation expenses ope cfPrior1YearDuration_NonConsolidatedMember19426000JPY
Share based compensation expenses ope cfCurrentYearDuration_NonConsolidatedMember41727000JPY
Increase decrease in provision for retirement benefits ope cfPrior1YearDuration_NonConsolidatedMember-569000JPY
Increase decrease in provision for retirement benefits ope cfCurrentYearDuration_NonConsolidatedMember1241000JPY
Interest and dividends income ope cfPrior1YearDuration_NonConsolidatedMember-2150000JPY
Interest and dividends income ope cfCurrentYearDuration_NonConsolidatedMember-3952000JPY
Interest expenses ope cfPrior1YearDuration_NonConsolidatedMember4597000JPY
Interest expenses ope cfCurrentYearDuration_NonConsolidatedMember5234000JPY
Issuance cost of share acquisition rights ope cfPrior1YearDuration_NonConsolidatedMember7202000JPY
Issuance cost of share acquisition rights ope cfCurrentYearDuration_NonConsolidatedMember7177000JPY
Stock issuance cost ope cfPrior1YearDuration_NonConsolidatedMember10394000JPY
Stock issuance cost ope cfCurrentYearDuration_NonConsolidatedMember9222000JPY
Foreign exchange losses gains ope cfPrior1YearDuration_NonConsolidatedMember-28429000JPY
Foreign exchange losses gains ope cfCurrentYearDuration_NonConsolidatedMember10337000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YearDuration_NonConsolidatedMember－JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration_NonConsolidatedMember-31306000JPY
Decrease increase in inventories ope cfPrior1YearDuration_NonConsolidatedMember764000JPY
Decrease increase in inventories ope cfCurrentYearDuration_NonConsolidatedMember662000JPY
Decrease increase in prepaid expenses ope cfPrior1YearDuration_NonConsolidatedMember3943000JPY
Decrease increase in prepaid expenses ope cfCurrentYearDuration_NonConsolidatedMember2794000JPY
Decrease increase in accounts receivable other ope cfPrior1YearDuration_NonConsolidatedMember-50506000JPY
Decrease increase in accounts receivable other ope cfCurrentYearDuration_NonConsolidatedMember-199872000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YearDuration_NonConsolidatedMember5575000JPY
Decrease increase in consumption taxes refund receivable ope cfCurrentYearDuration_NonConsolidatedMember5921000JPY
Decrease increase in advance payment ope cfPrior1YearDuration_NonConsolidatedMember-198366000JPY
Decrease increase in advance payment ope cfCurrentYearDuration_NonConsolidatedMember147229000JPY
Increase decrease in accounts payable other ope cfPrior1YearDuration_NonConsolidatedMember-141352000JPY
Increase decrease in accounts payable other ope cfCurrentYearDuration_NonConsolidatedMember12858000JPY
Increase decrease in contract liabilities ope cfPrior1YearDuration_NonConsolidatedMember－JPY
Increase decrease in contract liabilities ope cfCurrentYearDuration_NonConsolidatedMember110000000JPY
Other net ope cfPrior1YearDuration_NonConsolidatedMember11504000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass